News
Vertex (VERX) Earnings Expected to Grow: Should You Buy?
Vertex (VERX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives
Transcat, Inc. (TRNS) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Transcat, Inc. (TRNS) reports results for the quarter ended September 2025. While this widely-known consensus
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q3 Release
Wall Street expects a year-over-year increase in earnings on higher revenues when TG Therapeutics (TGTX) reports results for the quarter ended September 2025. While this widely-known consensus
QuinStreet (QNST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects QuinStreet (QNST) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Palomar (PLMR) to Report Q3 Results: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Palomar (PLMR) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Palantir Technologies Inc. (PLTR) Earnings Expected to Grow: Should You Buy?
The market expects Palantir Technologies Inc. (PLTR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This
Krystal Biotech, Inc. (KRYS) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Krystal Biotech, Inc. (KRYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Idexx Laboratories (IDXX) reports results for the quarter ended September 2025. While this widely-known consensus
Helios Technologies (HLIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Helios Technologies (HLIO) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Hologic (HOLX) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Halozyme Therapeutics (HALO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Hims & Hers Health, Inc. (HIMS) reports results for the quarter ended September 2025. While this widely-known
Freshpet (FRPT) Reports Next Week: Wall Street Expects Earnings Growth
Freshpet (FRPT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook
Diamondback Energy (FANG) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Diamondback Energy (FANG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Exact Sciences (EXAS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Coterra Energy (CTRA) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Coterra Energy (CTRA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Analysts Estimate Capital Southwest (CSWC) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when Capital Southwest (CSWC) reports results for the quarter ended September 2025. While this widely-known consensus
Analysts Estimate Castle Biosciences, Inc. (CSTL) to Report a Decline in Earnings: What to Look Out for
The market expects Castle Biosciences, Inc. (CSTL) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known
Crescent Energy (CRGY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year decline in earnings on higher revenues when Crescent Energy (CRGY) reports results for the quarter ended September 2025. While this widely-known consensus
Earnings Preview: Corebridge Financial (CRBG) Q3 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Corebridge Financial (CRBG) reports results for the quarter ended September 2025. While this widely-known consensus
BWX Technologies (BWXT) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when BWX Technologies (BWXT) reports results for the quarter ended September 2025. While this widely-known consensus
Cipher Mining Inc. (CIFR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
The market expects Cipher Mining Inc. (CIFR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy?
The market expects BioCryst Pharmaceuticals (BCRX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This
Axsome Therapeutics (AXSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Axsome Therapeutics (AXSM) reports results for the quarter ended September 2025. While this widely-known consensus
Earnings Preview: Bruker (BRKR) Q3 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when Bruker (BRKR) reports results for the quarter ended September 2025. While this widely-known consensus outlook is